Hematopoietic stem cell transplantation to improve prognosis in aggressive monomorphic epitheliotropic intestinal T-cell lymphoma
MEITL is an aggressive disease resistant to conventional therapy. Therefore, intensive chemotherapy followed by upfront allo-HSCT should be considered upon diagnosis. These findings underscore the need for novel therapeutic strategies and further investigation into optimizing treatment protocols for MEITL.
Authors
- Young‐Woo Jeon (ORCID: https://orcid.org/0000-0003-3362-8200)
- Seok Lee
- Seok‐Goo Cho (ORCID: https://orcid.org/0000-0002-5429-4839)
- Byung‐Sik Cho (ORCID: https://orcid.org/0000-0002-4524-6616)
- Silvia Park (ORCID: https://orcid.org/0000-0003-2845-2933)
- Hee-Je Kim
- Byung‐Su Kim (ORCID: https://orcid.org/0000-0002-7210-316X)
- Gi June Min (ORCID: https://orcid.org/0000-0001-7636-4693)
- Daehun Kwag (ORCID: https://orcid.org/0000-0003-3353-882X)
- Jong Wook Lee (ORCID: https://orcid.org/0000-0003-2949-4166)
- Yoo‐Jin Kim (ORCID: https://orcid.org/0000-0001-6653-2956)
- Sung Eun Lee (ORCID: https://orcid.org/0000-0002-6402-7259)
- Sung Soo Park (ORCID: https://orcid.org/0000-0002-1779-8683)
- Jae-Ho Yoon
- Yoon‐Sang Oh (ORCID: https://orcid.org/0000-0002-1566-6265)
- Chang‐Ki Min (ORCID: https://orcid.org/0000-0002-1940-0392)
- Tong Yoon Kim (ORCID: https://orcid.org/0000-0002-9559-992X)
- Ki-Seong Eom
Institutions
- The Catholic University of Korea Yeouido St. Mary's Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3389/fonc.2024.1388623
- Citations
- 7
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.97
Funders
- Korea Health Industry Development Institute